# ARREST PAD (Peripheral Arterial Disease)

> **NCT00153166** · PHASE2,PHASE3 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 76 (actual)

## Conditions studied

- Arterial Occlusive Disease
- Intermittent Claudication
- Insulin Resistance

## Interventions

- **DRUG:** atorvastatin and pioglitazone
- **DRUG:** atorvastatin/placebo
- **DRUG:** pioglitazone/placebo
- **DRUG:** placebo/placebo

## Key facts

- **NCT ID:** NCT00153166
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2010-11
- **Final completion:** 2011-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2014-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00153166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00153166, "ARREST PAD (Peripheral Arterial Disease)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00153166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*